Posted by ABMN Staff on May 16th, 2024
Teladoc Health (NYSE:TDOC – Get Free Report) had its target price dropped by stock analysts at Bank of America from $16.50 to $13.50 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral”...
More of this article »